Sanjeev Khindri

Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study

Hilary J. Goldberg, Sergio Harari, Vincent Cottin et al. · European Respiratory Journal · 2015 · 104 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD

Kai-Michael Beeh, Frank Wagner, Sanjeev Khindri et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2011 · 63 citations

Pharmacy, Pharmacotherapy, Exercise Testing +16

<i>In Vitro–In Vivo</i> Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler ^®

Jeffry G. Weers, Andrew Clark, Nagaraja Rao et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2014 · 50 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5&amp;nbsp;&amp;micro;g compared with tiotropium 18&amp;nbsp;&amp;micro;g in patients with&amp;nbsp;COPD

Gregory Feldman, François Maltais, Sanjeev Khindri et al. · International Journal of COPD · 2016 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants

Vassilios Aslanis, Robert J. Slack, Alison C. MacKinnon et al. · Cancer Chemotherapy and Pharmacology · 2023 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9